Search

everythinglearnresearchcommunity

for

Search:↓

The document reports findings on genetic research, including ethical concerns about genome editing, improved diagnosis of mitochondrial mutations, solving inherited eye diseases, confirming gene roles in epilepsy, linking a gene to aneurysms, and identifying genes associated with age-related macular degeneration.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

The document concludes that skin and nail changes can indicate various underlying health conditions.

Metal-organic frameworks help heal wounds by effectively delivering medicine.

Iron deficiency is linked to female pattern hair loss.

Shock wave therapy improved muscle function and movement in children with spastic cerebral palsy.

High levels of ceruloplasmin might indicate more severe toenail fungus.

Higher IL-21 levels may help predict alopecia areata activity.

Combining microneedling with platelet-rich plasma enhances skin repair and collagen production but may not offer significant extra benefits.

Alopecia areata is an autoimmune disease affecting hair follicles and may harm heart health.

Women with acne after adolescence are more likely to have PCOS and should be checked for it.

PRP treatment may increase hair density and reduce hair loss, but more research is needed.

The document suggests various treatments for PCOS, including medication for menstrual issues, insulin resistance, and excess hair, as well as fertility treatments, while highlighting the need for personalized care and lifestyle changes.

New drugs for rheumatoid arthritis show improvement but have side effects and are not a cure.

PCOS is linked to low-grade chronic inflammation.

Women with idiopathic hirsutism and PCOS have higher RBP4 levels, and PCOS is linked to greater insulin resistance; weight management may help both conditions.

Umbilical cord cells safely improve healing in long-term nonhealing wounds better than a placebo.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

People with psoriasis and depression have lower BDNF levels, which could help measure depression in those with psoriasis.

Lower vitamin D levels are linked to more severe hair loss in men.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The document explains the difficulty in diagnosing and treating brain diseases caused by the immune system and stresses the need for quick and accurate tests.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Estrogen therapy can reduce skin aging but has cancer risks.